Kalif Eliyahu Sharon

Insider profile

Kalif Eliyahu Sharon's trades of Teva Pharmaceutical Industries Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-18 2026-05-14 PlS Planned sale
87,018 +38.3%
340.26
US$543,688
87,018 +38.3% 340.26 US$543,688
2026-05-14 2026-05-14 PrS Proposed sale
26,789
323.78
US$315,343
26,789 323.78 US$315,343
2026-03-02 2026-02-26 PlS Planned sale
25,133 -41.6%
37.44
US$1,433,578
25,133 -41.6% 37.44 US$1,433,578
2026-02-26 2026-02-26 PrS Proposed sale
345,810
33.64
US$11,634,702
345,810 33.64 US$11,634,702
2025-06-16 2025-06-12 PlS Planned sale
55,775 -12.1%
17.08
US$952,464
55,775 -12.1% 17.08 US$952,464
2025-06-12 2025-06-12 PrS Proposed sale
55,775
17.08
US$952,466
55,775 17.08 US$952,466
2025-03-04 2025-02-28 PlS Planned sale
55,750 -27.4%
16.21
US$903,462
55,750 -27.4% 16.21 US$903,462
2025-02-28 2025-02-28 PrS Proposed sale
55,750
16.21
US$903,463
55,750 16.21 US$903,463
2024-03-07 2024-03-06 PlS Planned sale
77,550 -27.6%
13.52
US$1,048,119
77,550 -27.6% 13.52 US$1,048,119
2023-08-09 2023-08-07 S Sale
35,125 -26.2%
9.73
US$341,889
35,125 -26.2% 9.73 US$341,889
2022-08-24 2022-08-22 PlS Planned sale
55,500 -85.5%
10.07
US$558,696
55,500 -85.5% 10.07 US$558,696